KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Common Equity (2016 - 2025)

Historic Common Equity for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $3.1 billion.

  • Encompass Health's Common Equity rose 1733.92% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 1733.92%. This contributed to the annual value of $2.8 billion for FY2024, which is 2383.38% up from last year.
  • As of Q3 2025, Encompass Health's Common Equity stood at $3.1 billion, which was up 1733.92% from $3.0 billion recorded in Q2 2025.
  • Over the past 5 years, Encompass Health's Common Equity peaked at $3.1 billion during Q3 2025, and registered a low of $1.7 billion during Q3 2022.
  • Moreover, its 5-year median value for Common Equity was $2.4 billion (2021), whereas its average is $2.4 billion.
  • In the last 5 years, Encompass Health's Common Equity tumbled by 2436.97% in 2022 and then soared by 2559.65% in 2023.
  • Quarter analysis of 5 years shows Encompass Health's Common Equity stood at $2.4 billion in 2021, then dropped by 22.52% to $1.8 billion in 2022, then increased by 23.48% to $2.3 billion in 2023, then grew by 23.83% to $2.8 billion in 2024, then rose by 12.15% to $3.1 billion in 2025.
  • Its Common Equity was $3.1 billion in Q3 2025, compared to $3.0 billion in Q2 2025 and $2.9 billion in Q1 2025.